Dr. Raquel Gerson Cwilich, a specialist in Internal Medicine and Clinical Oncology, emphasized the importance of joining efforts between the public and private sectors, support groups, and patients in the fight against breast cancer, particularly triple-negative breast cancer. She highlighted the need to address all types of cancer comprehensively, not just this subtype.
Her concern for the situation of many unprotected and lonely patients in their battle against the disease arose from her experience at the General Hospital. In an interview where she expressed gratitude for the support received, she urged the establishment of effective strategies that promote early detection and access to appropriate treatments. The lack of a national cancer registry in Mexico is one of the challenges facing this task.
Dr. Gerson pointed out the difficulty of diagnosing triple-negative breast cancer at early stages due to the absence of specific hormonal markers. She identified this subgroup as one of the most challenging, given its rapid progression. She explained that, while there have been advancements in its treatment, it remains complicated to treat and diagnose.
She emphasized the importance of a comprehensive approach that not only destroys cancer cells but also strengthens the immune system to fight the disease. Gerson underlined that, despite efforts for early detection, mortality from breast cancer has not decreased as expected in Mexico. Early detection and access to effective treatments continue to be critical areas for improvement.
Dr. Raquel Gerson Cwilich advocated for greater awareness, the formation of specialized associations such as the Mexican Association of Mastology, and the need for a national cancer registry. She highlighted the importance of biopsy to determine the type of tumor and thus decide the appropriate treatment.
In a personal reflection, Gerson called for collaboration and collective action to confront this disease. She stressed the importance of education and awareness to improve care and available treatments. She acknowledged that the fight against cancer, especially triple-negative, is a continuous effort that requires the unity of all involved sectors.
